Clinical Trial Update: A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers. [Phase 1]

View source ↗

Summary

This Phase 1, blinded, dose-escalation study evaluated the pharmacokinetics, safety, and tolerability of repeat inhaled doses of GW870086X in healthy adult male…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW870086X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED